Resources

To mark World Cancer Research Day, we are proud to share this film celebrating innovation in immunotherapy, the passion of our team working together in scientific discovery and our shared goal of developing new approaches for patients with cancer.

Barry Callebaut, the world’s leading manufacturer of high-quality chocolate and cocoa solutions, has moved into Colworth Science Park’s food tech incubator Gastronomica.

Latest Press Release Announcing Momentum Pharma (BIA member organisation) growth, launching a business in Australia to better serve the Australia and APAC region.

Positive interim review marks key milestone for POLB 001 clinical development

New service brings senior regulatory expertise into the early development window, when strategic decisions can have the greatest impact. DLRC, an award-winning global regulatory and market access consultancy that supports the development and licensing of pharmaceutical, biotech, advanced therapy, and medtech products worldwide, launches Regulatory Spark, a new fixed-fee, fast-turnaround service created for early-stage innovators.

Engitix announced the appointment of Sonia Quaratino, MD, PhD in the newly created role of Executive Vice President (EVP) Chief Medical Officer (CMO).

PACE and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns

Regional cluster updates, fresh OLS data, NICE's Enhertu approval and £89.9m for Chemify - catch up on this week's CEO blog.

Global drug development consultancy Boyds has reported robust revenue growth for the financial year ending March 2026, despite the slowdown in the global biotech and pharma markets.

Analysis for Innovators (A4I) is a funding programme that helps UK SMEs overcome complex measurement, testing and analysis challenges by providing access to world-class expertise, specialist facilities and scientific knowledge from leading UK measurement organisations, including NML.

Causeway Sensors and Fusion Antibodies share a case study on how TITAN’s real-time, at-line analytics detected key harvest yield differences by Day 3, enabling early process intervention and smarter resource allocation.

Coulter Partners, the global advisor building leadership teams for Health, Science and Technology innovation businesses, today announces the appointment of Carlos Gómez-Arnau, Doug Roberts, and Stuart Penney as Client Partners. These strategic hires further strengthen the firm's international presence and reinforce its commitment to supporting clients across key healthcare, life sciences, and biotechnology markets.

Brainomix, a global leader in AI-powered medical imaging, today announced that it has been selected to join Future Fifty, the UK’s most prestigious scale-up programme, recognizing the company as one of the country’s most high-potential technology businesses.

New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs

Autumn Budget, AI regulation and new transatlantic partnerships: how we’re driving scale and capital for UK biotechs.

Peptide drug discovery uses peptides to investigate biological targets and develop potential therapeutics. The blog covers their key advantages, applications in screening and SAR, major challenges such as stability and delivery, optimisation strategies, and how o2h Discovery supports peptide synthesis and drug discovery workflows.

The NML has published its Annual Review 2025, reflecting on a year of scientific achievement, collaboration and investment in the future of UK chemical and biological measurement science. The Review showcases how the NML’s trusted measurement expertise is enabling innovation to be translated into real-world impact, supporting UK growth and regional expertise, and strengthening public confidence in policy and government decisions. If you would like to discuss any of the work featured in this Review or explore future collaboration opportunities with the NML, please contact [email protected]

Join Winston Taylor and Raymond James on 23rd September 2026 in London, as we bring together leaders who've built, scaled, and exited growth-stage businesses. A sharp, practical discussion on the routes to growth, liquidity, and exit.